Table 3 International recommendations of respiratory component of PPE for protection of HCWs performing AGPs in suspected or conformed COVID-19 patients
International governing body/institution | Face filtering piece (FFP) (in addition to other PPE) | Powered air-purifying respirator (PAPR) (in addition to other PPE) |
|---|---|---|
European Centre for Disease (ECDC) | FFP2/FFP3 | Use of PAPR not considered |
Centers for Disease Control and Prevention (CDC) | At least N95 | Use of PAPR not considered |
Public Health of England | FFP3 | Use of PAPR not considered |
The Communicable Disease Network Australia (CDNA) | FFP/N95 | Consider the use of PAPR if remaining in the room with patient with suspected/confirmed COVID-19 positive patient longer than 1 h |